The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
At the inaugural CHOC/UCI Rare Disease Conference, providers discussed plans for extended research, collaboration and treatment strategies.
CHOC doctors led a study that helped garner authorization by the FDA of a digital diagnosis aid that will help to diagnose autism.
The Thompson Autism and Neurodevelopmental Center addresses autism defined core symptoms through a medical home approach that reduces unmet healthcare needs.
Dr. Tom Megerian, clinical director of the Thompson Autism and Neurodevelopmental Center at CHOC, discusses research suggesting children may outgrow autism.